Sandbox Reserved 1703: Difference between revisions
No edit summary |
No edit summary |
||
Line 3: | Line 3: | ||
==Introduction== | ==Introduction== | ||
Metabotropic glutamate receptors are found in the central nervous system and play a critical role in modulating cell excitability and synaptic transmission<ref name="Lin">Lin, Shuling, et al. “Structures of GI-Bound Metabotropic Glutamate Receptors mglu2 and mglu4.” Nature News, Nature Publishing Group, 16 June 2021,https://www.nature.com/articles/s41586-021-03495-2></ref>. Glutamate is the main neurotransmitter in the brain and activates 8 different types of metabotropic glutamate receptors<ref name="Seven">Seven, Alpay B., et al. “G-Protein Activation by a Metabotropic Glutamate Receptor.” Nature News, Nature Publishing Group, 30 June 2021, https://www.nature.com/articles/s1586-021-03680-3</ref>[https://en.wikipedia.org/wiki/Metabotropic_glutamate_receptor_2 Metabotropic Glutamate Receptor 2](mGlu2) is a member of the Class C GPCR Family and can further be classified into the Group II subgroup of metabotropic receptors. Since mGlu2 is a part of the Class C GPCR family, it undergoes small conformational changes to the transmembrane domain (TMD) to move from the inactive to the fully active structure<ref name="Lin" />. Functionality of mGlu2 will be dependent on the concentration of glutamate. Higher concentrations of glutamate will promote stronger signal transduction from the extracellular domain to the transmembrane domain. | Metabotropic glutamate receptors are found in the central nervous system and play a critical role in modulating cell excitability and synaptic transmission<ref name="Lin">Lin, Shuling, et al. “Structures of GI-Bound Metabotropic Glutamate Receptors mglu2 and mglu4.” Nature News, Nature Publishing Group, 16 June 2021,https://www.nature.com/articles/s41586-021-03495-2></ref>. Glutamate is the main neurotransmitter in the brain and activates 8 different types of metabotropic glutamate receptors<ref name="Seven">Seven, Alpay B., et al. “G-Protein Activation by a Metabotropic Glutamate Receptor.” Nature News, Nature Publishing Group, 30 June 2021, https://www.nature.com/articles/s1586-021-03680-3</ref>. | ||
[https://en.wikipedia.org/wiki/Metabotropic_glutamate_receptor_2 Metabotropic Glutamate Receptor 2](mGlu2) is a member of the Class C GPCR Family and can further be classified into the Group II subgroup of metabotropic receptors. Since mGlu2 is a part of the Class C GPCR family, it undergoes small conformational changes to the transmembrane domain (TMD) to move from the inactive to the fully active structure<ref name="Lin" />. Functionality of mGlu2 will be dependent on the concentration of glutamate. Higher concentrations of glutamate will promote stronger signal transduction from the extracellular domain to the transmembrane domain. | |||
mGlu2 plays vital roles in memory formation, pain management, and addiction, which makes it an important drug target for Parkinson’s Disease<ref name="Zhang">Zhang, Zhu, et al. “Roles of Glutamate Receptors in Parkinson's Disease.” MDPI, Multidisciplinary Digital Publishing Institute, 6 Sept. 2019, https://dx.doi.org/10.3390%2Fijms20184391.></ref>, Schizophrenia (blue link), Cocaine Addiction<ref name="Yang">Yang, Hong-Ju, et al. “Deletion of Type 2 Metabotropic Glutamate Receptor Decreases Sensitivity to Cocaine Reward in Rats.” Cell Reports, U.S. National Library of Medicine, 11 July 2017, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5555082/.></ref>, and many other neurological conditions. | mGlu2 plays vital roles in memory formation, pain management, and addiction, which makes it an important drug target for Parkinson’s Disease<ref name="Zhang">Zhang, Zhu, et al. “Roles of Glutamate Receptors in Parkinson's Disease.” MDPI, Multidisciplinary Digital Publishing Institute, 6 Sept. 2019, https://dx.doi.org/10.3390%2Fijms20184391.></ref>, Schizophrenia (blue link), Cocaine Addiction<ref name="Yang">Yang, Hong-Ju, et al. “Deletion of Type 2 Metabotropic Glutamate Receptor Decreases Sensitivity to Cocaine Reward in Rats.” Cell Reports, U.S. National Library of Medicine, 11 July 2017, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5555082/.></ref>, and many other neurological conditions. |